November 02, 2017 13:00 - 14:00
The U.S. courts are deferring to the business judgment of directors in M&A transactions that have been properly approved by shareholders. This deference is making it more difficult for investors to advance post-closing damages claims. The net effect? Declining M&A litigation in the U.S., and alignment with the Canadian courts' approach to reviewing M&A transactions.
For more information or to register, click here.